Inovio Pharmaceuticals Inc (INO): There are 2 trials, heterologous and hom...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	13
Posts	3218
Boards Moderated	0
Alias Born	04/26/2007

Lakers_w

Re: Lakers_w post# 39870

Saturday, 02/05/2022 4:08:52 PM

Saturday, February 05, 2022 4:08:52 PM

There are 2 trials, heterologous and homologous.
The heterologous finished recruiting before Lunar New Year (Feb 1) and Beijing Winter Olympic (Feb 3). ppl starts leaving for 2-wk vacation between Fri 1/2–1/31. 4 wks after 1/28, blood test begins. Interim data should be available early March. Things move much faster in China. Together with WHO’s STV data from Philippines - WHO moves fast as well as you saw news from Manila Bulletin early Jan 2022 - 4800 is progressing well. Coronavac desperately needs 4800 booster as Sinovac’s is not effective. Huge China and worldwide market as China donates/sells Coronavac oversea, Vaccine Diplomacy. It’s the most popular vaccine outside China as well.
Officially, China only allows vaccine made in China To be used in China. Therefore, 4800/pGX9501 has a huge advantage. Pfizer, Moderna have zero chance in China. China will push pGX9501 in Vaccine Diplomacy as well at least as Booster. This should take market share from other Vaccines.